Clinical Trials Browser

Phase 4 × Neoplasm Metastasis × liposomal doxorubicin × Clear all

NCT00128778 2023-03-06

Maintenance Treatment With Liposomal Doxorubicin (Caelyx) in Metastatic Breast Cancer Patients

Phase 4 Completed

Breast Neoplasms, Neoplasm Metastasis